Levocertirizine

{x}Pharmacological Category:Second Generation; Piperazine Derivative
{x}MOA:Selectively competes with histamine for H1 receptor sites on effector cells in the GI, blood vessels, and respiratory tract
{b}Adverse Effects: >10%: diarrhea 1-10%: drowsiness, fatigue, constipation, vomiting, xerostomia, otitis media, nasopharyngitis, cough, epistaxis, fever
{ut}Contraindications: Hypersensitivity to levocetirizine or cetirizine, end stage renal disease, hemodialysis, infants and children 6 months to 1